---
title: "Rituximab Subcut"
ocid: "ocds-r6ebe6-0000788020"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000788020"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000788020.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000788020.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-01-31"
---

# Rituximab Subcut

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000788020

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000788020)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000788020.json)

## Summary

The Common Services Agency, known as NHS National Services Scotland (NSS), has completed the procurement process for the supply of Rituximab Subcut (Rituximab (MabThera) Vial 1400 MG/11.7 ML), under the tender ID NP93420. This procurement falls within the health industry category and aims to serve all entities constituted under the National Health Service (Scotland) Act 1978, including any Integrated Joint Boards established pursuant to Public Bodies (Joint Working) Scotland Act. The contracting authority is located at 1 South Gyle Crescent, Edinburgh, UKM, with the procurement completed through a limited procedure method due to the urgent demands driven by the Covid-19 pandemic. This contract, valued at £2,404,041, was awarded to Roche Products Ltd on 30 January 2025.

This tender opens significant opportunities for businesses involved in the supply of pharmaceutical goods, especially those capable of providing specialised healthcare products. Large-scale suppliers of medical drugs and treatments could leverage this procurement to grow their market presence within the NHS Scotland framework. The single-supplier framework agreement, with a 12-month modification period, underscores the demand for reliable suppliers who can meet increased and urgent demands during health crises, thus favouring established and large-scale healthcare suppliers ready to deliver consistent and substantial product volumes.

## Notice

Supply of Rituximab (MabThera) Vial 1400 MG/11.7 ML to NHS Scotland.

### Lot Information

Lot 1

Supply of Rituximab (MabThera) Vial 1400 MG/11.7 ML to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.

### Procurement Information

This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN522908 |
| Notice type | OJEU - F15 - Voluntary Ex Ante Transparency Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 31 Jan 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 30 Jan 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £2,404,041 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ROCHE PRODUCTS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 31 Jan 2025 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN522908

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN522908
  Rituximab Subcut - Supply of Rituximab (MabThera) Vial 1400 MG/11.7 ML to NHS Scotland.

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- http://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=788020
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000788020

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000788020. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000788020.json.